Publications by authors named "Bram Sweron"

Claim this Profile
O
Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia.
Quentin Van Thillo, Jolien De Bie, Janith A Seneviratne, Sofie Demeyer, Sofia Omari, Bram Sweron

Nat Commun· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development.
Charles E de Bock, Michelle Down, Kinsha Baidya, Bram Sweron, Andrew W Boyd

Haematologica· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development.
Charles E de Bock, Sofie Demeyer, Sandrine Degryse, Delphine Verbeke, Bram Sweron

Cancer Discov· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel FLT3 kinase inhibitors.
Daphnie Pauwels, Hugo Klaassen, Idoya Lahortiga, Amuri Kilonda, Kris Jacobs, Bram Sweron

Eur J Med Chem· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia.
Kim De Keersmaecker, Zeynep Kalender Atak, Ning Li, Carmen Vicente, Stephanie Patchett, Bram Sweron

Nat Genet· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The N676D and G697R mutations in the kinase domain of FLT3 confer resistance to the inhibitor AC220.
Daphnie Pauwels, Bram Sweron, Jan Cools

Haematologica· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis